These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8027006)

  • 21. Adaptation of Pseudomonas aeruginosa ATCC 15442 to didecyldimethylammonium bromide induces changes in membrane fatty acid composition and in resistance of cells.
    Méchin L; Dubois-Brissonnet F; Heyd B; Leveau JY
    J Appl Microbiol; 1999 May; 86(5):859-66. PubMed ID: 10347880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outer membrane proteins and elastase of Pseudomonas aeruginosa after the postantibiotic effect induced by amikacin.
    Hostacká A; Karelová E
    Chemotherapy; 1997; 43(2):118-22. PubMed ID: 9084920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of imipenem resistance acquired by three Pseudomonas aeruginosa strains during imipenem therapy.
    Vurma-Rapp U; Kayser FH; Hadorn K; Wiederkehr F
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):580-7. PubMed ID: 2120059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that a novel quaternary compound and its organic N-chloramine derivative do not select for resistant mutants of Pseudomonas aeruginosa.
    De Silva M; Ning C; Ghanbar S; Zhanel G; Logsetty S; Liu S; Kumar A
    J Hosp Infect; 2015 Sep; 91(1):53-8. PubMed ID: 26122622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa.
    Ikonomidis A; Tsakris A; Kantzanou M; Spanakis N; Maniatis AN; Pournaras S
    FEMS Microbiol Lett; 2008 Feb; 279(1):36-9. PubMed ID: 18070070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial activity of chensinin-1b, a peptide with a random coil conformation, against multiple-drug-resistant Pseudomonas aeruginosa.
    Shang D; Meng X; Zhang D; Kou Z
    Biochem Pharmacol; 2017 Nov; 143():65-78. PubMed ID: 28756209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
    Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
    Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiresistant serotype O 12 Pseudomonas aeruginosa: evidence for a common strain in Europe.
    Pitt TL; Livermore DM; Pitcher D; Vatopoulos AC; Legakis NJ
    Epidemiol Infect; 1989 Dec; 103(3):565-76. PubMed ID: 2514112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mode of action of 2-(thiazol-2-ylthio)-1beta-methylcarbapenems against Pseudomonas aeruginosa: the impact of outer membrane permeability and the contribution of MexAB-OprM efflux system.
    Eguchi K; Ueda Y; Kanazawa K; Sunagawa M; Gotoh N
    J Antibiot (Tokyo); 2007 Feb; 60(2):129-35. PubMed ID: 17420563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth inhibitory and biocidal activity of some isothiazolone biocides.
    Collier PJ; Ramsey AJ; Austin P; Gilbert P
    J Appl Bacteriol; 1990 Oct; 69(4):569-77. PubMed ID: 2292520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa.
    Yee YC; Kisslinger B; Yu VL; Jin DJ
    J Antimicrob Chemother; 1996 Jul; 38(1):133-7. PubMed ID: 8858465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa with reference to their lipopolysaccharide compositions.
    Hasegawa M; Kobayashi I; Saika T; Nishida M
    Chemotherapy; 1997; 43(5):323-31. PubMed ID: 9309365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudomonas aeruginosa PAO1 adapted to 2-phenoxyethanol shows cross-resistance to dissimilar biocides and increased susceptibility to antibiotics.
    Abdel Malek SM; Badran YR
    Folia Microbiol (Praha); 2010 Nov; 55(6):588-92. PubMed ID: 21253903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a structural model of Pseudomonas aeruginosa outer membrane protein OprM, an efflux component involved in intrinsic antibiotic resistance.
    Wong KK; Brinkman FS; Benz RS; Hancock RE
    J Bacteriol; 2001 Jan; 183(1):367-74. PubMed ID: 11114937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to ciprofloxacin appearing during therapy.
    Chin NX; Clynes N; Neu HC
    Am J Med; 1989 Nov; 87(5A):28S-31S. PubMed ID: 2511760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outer membrane proteins of polymyxin resistant Pseudomonas aeruginosa: effect of magnesium depletion.
    Shand GH; Anwar H; Brown MR
    J Antimicrob Chemother; 1988 Dec; 22(6):811-21. PubMed ID: 2854118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
    Pfaller MA; Bassetti M; Duncan LR; Castanheira M
    J Antimicrob Chemother; 2017 May; 72(5):1386-1395. PubMed ID: 28165526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of large amounts of lipopolysaccharides from Pseudomonas aeruginosa cells reduces their susceptibility to colistin.
    Yokota SI; Hakamada H; Yamamoto S; Sato T; Shiraishi T; Shinagawa M; Takahashi S
    Int J Antimicrob Agents; 2018 Jun; 51(6):888-896. PubMed ID: 29432867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.